These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 8753752)

  • 1. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy.
    Wright GL; Grob BM; Haley C; Grossman K; Newhall K; Petrylak D; Troyer J; Konchuba A; Schellhammer PF; Moriarty R
    Urology; 1996 Aug; 48(2):326-34. PubMed ID: 8753752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine.
    Pinto JT; Qiao C; Xing J; Suffoletto BP; Schubert KB; Rivlin RS; Huryk RF; Bacich DJ; Heston WD
    Prostate; 2000 Dec; 45(4):304-14. PubMed ID: 11102955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues.
    Chang SS; Reuter VE; Heston WD; Hutchinson B; Grauer LS; Gaudin PB
    Cancer; 2000 Jan; 88(2):407-15. PubMed ID: 10640975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.
    Vaz S; Hadaschik B; Gabriel M; Herrmann K; Eiber M; Costa D
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):9-15. PubMed ID: 31654093
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells.
    Sommer U; Siciliano T; Ebersbach C; Beier AK; Stope MB; Jöhrens K; Baretton GB; Borkowetz A; Thomas C; Erb HHH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer.
    Paller CJ; Piana D; Eshleman JR; Riel S; Denmeade SR; Isaacsson Velho P; Rowe SP; Pomper MG; Antonarakis ES; Luo J; Eisenberger MA
    Prostate; 2019 Oct; 79(14):1597-1603. PubMed ID: 31361358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells.
    Kranzbühler B; Salemi S; Umbricht CA; Müller C; Burger IA; Sulser T; Eberli D
    Prostate; 2018 Jul; 78(10):758-765. PubMed ID: 29633296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of prostate specific membrane antigen/folate hydrolase transcription by an enhancer.
    Noss KR; Wolfe SA; Grimes SR
    Gene; 2002 Feb; 285(1-2):247-56. PubMed ID: 12039052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent effects of dutasteride on prostate-specific membrane antigen (PSMA) expression and uptake of
    Kranzbühler B; Salemi S; Umbricht CA; Deberle LM; Müller C; Burger IA; Hermanns T; Sulser T; Eberli D
    Prostate; 2019 Sep; 79(12):1450-1456. PubMed ID: 31233227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
    Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
    Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Ben Rais N; Ouertani L; Nouira Y; Horchani A; Oueslati R
    J Exp Clin Cancer Res; 2010 Dec; 29(1):171. PubMed ID: 21189143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer.
    Murga JD; Moorji SM; Han AQ; Magargal WW; DiPippo VA; Olson WC
    Prostate; 2015 Feb; 75(3):242-54. PubMed ID: 25327687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the prostate-specific membrane antigen.
    Israeli RS; Powell CT; Corr JG; Fair WR; Heston WD
    Cancer Res; 1994 Apr; 54(7):1807-11. PubMed ID: 7511053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
    Montgomery BT; Young CY; Bilhartz DL; Andrews PE; Prescott JL; Thompson NF; Tindall DJ
    Prostate; 1992; 21(1):63-73. PubMed ID: 1379363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids.
    Troyer JK; Beckett ML; Wright GL
    Int J Cancer; 1995 Sep; 62(5):552-8. PubMed ID: 7665226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy.
    Lembessis P; Msaouel P; Halapas A; Sourla A; Panteleakou Z; Pissimissis N; Milathianakis C; Bogdanos J; Papaioannou A; Maragoudakis E; Dardoufas C; Dimopoulos T; Koutsilieris M
    Clin Chem Lab Med; 2007; 45(11):1488-94. PubMed ID: 17924845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen.
    Murphy GP; Barren RJ; Erickson SJ; Bowes VA; Wolfert RL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Kenny GM; Ragde H; Boynton AL; Holmes EH
    Cancer; 1996 Aug; 78(4):809-18. PubMed ID: 8756376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.